Detail Information of Genetic Polymorphisms
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0249 Transporter Info | ||||
| Gene Name | SLC29A3 | ||||
| Protein Name | Equilibrative nucleoside transporter 3 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Genetic Polymorphisms of DT (GPD) | |||||
| Genetic Polymorphism | rs780668 | ||||
| Site of GPD | chr10:71351651 (GRCh38.p12) | ||||
| GPD Type | SNP | ||||
| Allele(s) in dbSNP | C>T | ||||
| Minor Allele Frequency | T=0.4798/2403 (Global) | ||||
| Allele C | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
| Gemcitabine | Drug Info | Non-Small-Cell Lung Carcinoma | Irrelevant to the neutropenia and thrombocytopenia risk in patients (compare with Allele T) | [ 1] | |
| Genotypes CT + TT | Click to Show/Hide the Full List of Affected Drugs: 1 Drugs in Total | ||||
| Gemcitabine | Drug Info | Non-Small-Cell Lung Carcinoma | Correlated with the increased overall survival in patients (compare with genotype CC); Irrelevant to the progression-free survival in patients (compare with genotype CC) | [ 1] | |
| References | |||||
| 1 | Discovering novel SNPs that are correlated with patient outcome in a Singaporean cancer patient cohort treated with gemcitabine-based chemotherapy. BMC Cancer. 2018 May 11;18(1):555. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.